Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

60275 1492790397HCLSReviewGreeceApril2017.pdf
Energy Boardroom

On a quest to double sales, Akorn snags specialized rival VersaPharm in $440M deal

12.05.2014 / Fierce Pharma

Specialty generics maker Akorn has nabbed another niche player. Fresh off the closing of its eye-care-oriented buyout of Hi-Tech Pharmacal, the Lake Forest, IL-based drug company has snapped up VersaPharm for $440 million.

Cover_HCLS_GREECE LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: